Botulinum toxin type A in the treatment of focal, axillary and palmar hyperhidrosis and other hyperhidrotic conditions
- 1 November 1999
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 6 (S4) , s111-s115
Abstract
Focal essential hyperhidrosis is a common and often disabling disorder mainly involving the palms, axillae, face, and soles of the feet. Focal hyperhidrosis may also arise from several neurological or internal diseases. Current therapeutic options include topical aluminium chloride salts, systemic anticholinergic drugs, tap‐water iontophoresis, and a number of surgical approaches. However, none of these are entirely satisfactory. In recent studies, injection of botulinum toxin type A (BTX‐A) into the hyperhidrotic area has proved very effective in reducing or abolishing focal sweating of different aetiologies without major side effects. BTX‐A therefore has the potential to replace more invasive therapies.Keywords
This publication has 18 references indexed in Scilit:
- Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxinMuscle & Nerve, 1998
- Botulinum toxin for focal hyperhidrosis: technical considerations and improvements in applicationBritish Journal of Dermatology, 1998
- Botulinum A Neurotoxin for Axillary Hyperhidrosis No Sweat BotoxDermatologic Surgery, 1998
- Up‐to‐date Report of Botulinum Toxin Type A Treatment in Patients With Gustatory Sweating (Frey's Syndrome)The Laryngoscope, 1998
- Axilläre Hyperhidrose: Erfolgreiche Behandlung mit Botulinumtoxin-ADie Dermatologie, 1998
- Treatment of gustatory sweating with botulinum toxinAnnals of Neurology, 1997
- Botulinum toxin for palmar hyperhidrosisThe Lancet, 1997
- Endoscopic transthoracic sympathectomy: An efficient and safe method for the treatment of hyperhidrosisJournal of the American Academy of Dermatology, 1995
- Botulinum toxin and sweating.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- HyperhidrosisThe Lancet, 1994